Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Visual dysfunction in Parkinson's disease.

R L Rodnitzky1

  • 1Department of Neurology, University of Iowa College of Medicine, Iowa City, USA.

Clinical Neuroscience (New York, N.Y.)
|April 29, 2000
PubMed
Summary

Parkinson's disease (PD) impairs vision through retinal dopamine deficiency, affecting visual evoked potentials and contrast sensitivity. These subtle visual changes in Parkinson's disease patients may link to broader functional disabilities.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thalamic ependymoma presenting as recurrent subarachnoid hemorrhage.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2015
Same author

Driving with distraction in Parkinson disease.

Neurology·2006
Same author

Visual dysfunction in Parkinson disease without dementia.

Neurology·2005
Same author

Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism.

Acta neuropathologica·2002
Same author

Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.

Neurology·1999
Same author

Can calcium antagonists provide a neuroprotective effect in Parkinson's disease?

Drugs·1999

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Neurology

Background:

  • Parkinson's disease (PD) is associated with various visual dysfunctions.
  • Electrophysiologic and psychophysical tests reveal abnormalities in PD patients' visual function.

Purpose of the Study:

  • To investigate the role of retinal dopaminergic deficiency in Parkinson's disease visual dysfunction.
  • To explore the relationship between visual abnormalities and clinical symptoms in PD.

Main Methods:

  • Utilized electrophysiologic testing (visual evoked potentials) and psychophysical testing (color perception, visual contrast sensitivity).
  • Examined levodopa therapy's effect on visual function in PD patients and experimental parkinsonism models.

Main Results:

  • Prolonged visual evoked potential latencies and abnormal electroretinographic patterns were observed in PD.
  • Impaired color perception (blue-green axis) and visual contrast sensitivity (VCS) were documented in PD patients.
  • VCS impairment's orientation specificity suggests potential visual cortex involvement.

Conclusions:

  • Retinal dopamine deficiency is a significant factor in Parkinson's disease visual dysfunction.
  • Visual abnormalities in PD are often clinically occult but may underlie significant disabilities like gait freezing and hallucinations.

Related Experiment Videos